相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?
Sushanta Halder et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2023)
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer
Marie Grosgeorges et al.
SCIENTIFIC REPORTS (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification
Jean-Francois Delattre et al.
CANCER TREATMENT REVIEWS (2022)
Risk Factors for Colorectal Polyps and Cancer
Jared A. Sninsky et al.
Gastrointestinal Endoscopy Clinics of North America (2022)
Cause, Epidemiology, and Histology of Polyps and Pathways to Colorectal Cancer
Brian A. Sullivan et al.
Gastrointestinal Endoscopy Clinics of North America (2022)
Clinical management of metastatic colorectal cancer in the era of precision medicine
Fortunato Ciardiello et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management
Shailja C. Shah et al.
GASTROENTEROLOGY (2022)
BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape
Kristen K. Ciombor et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Influence of Diagnostic Delay on Survival Rates for Patients with Colorectal Cancer
Maria Padilla-Ruiz et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Construction of a Colorectal Cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms
Xuezhi Du et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2022)
Distribution of KRASG12C Somatic Mutations across Race, Sex, and Cancer Type
Amin H. Nassar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Gongmin Zhu et al.
MOLECULAR CANCER (2021)
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Leah H. Biller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy
Prakash Priyadarshi Praharaj et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series
Chengjing Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway
Xiaofeng Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
BRAFV600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database
Romain Cohen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Genetic and biological hallmarks of colorectal cancer
Jiexi Li et al.
GENES & DEVELOPMENT (2021)
The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
Rathasapa Patarat et al.
SCIENTIFIC REPORTS (2021)
High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome
Pinelopi Artemaki et al.
CLINICAL BIOCHEMISTRY (2020)
Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development
Arthur T. Kopylov et al.
MOLECULES (2020)
Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes Following Chemotherapeutic Treatment
Rebekah M. Engel et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Colorectal Cancer Immunotherapy: Options and Strategies
Nor Adzimah Johdi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Evangeline M. Foster et al.
FRONTIERS IN NEUROSCIENCE (2019)
Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches
Aaron J. Franke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
sCLU as prognostic biomarker and therapeutic target in osteosarcoma
Jinfeng Ma et al.
BIOENGINEERED (2019)
Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies
Christine M. Parseghian et al.
CLINICAL CANCER RESEARCH (2019)
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer
Sorbarikor Piawah et al.
CANCER (2019)
Brain clusterin protein isoforms and mitochondrial localization
Sarah K. Herring et al.
ELIFE (2019)
Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer
Atsushi Ogura et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Phase II Clinical Trial to Evaluate the Efficacy of Transanal Endoscopic Total Mesorectal Excision for Rectal Cancer
Sung Chan Park et al.
DISEASES OF THE COLON & RECTUM (2018)
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer
Tomoko Saito et al.
NATURE COMMUNICATIONS (2018)
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2
K. Chang et al.
ANNALS OF ONCOLOGY (2018)
Factors that influence treatment delay in patients with colorectal cancer
Irene Zarcos-Pedrinaci et al.
ONCOTARGET (2017)
Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
Yolanda Vidal Insua et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer
Sabina Pucci et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
New insights into colorectal cancer screening and early detection tests
Seyed Mohammad Amin Kormi et al.
COLORECTAL CANCER (2017)
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
Jean-Pierre Delord et al.
CLINICAL CANCER RESEARCH (2017)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015
Timothy J. Price et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death
Moonmoon Deb et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study
Michela Bertuzzi et al.
BMC CANCER (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Precision medicine and the FDA's draft guidance on laboratory-developed tests
Thomas J. Hwang et al.
NATURE BIOTECHNOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Colorectal cancer
Ernst J. Kuipers et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Translational Considerations on the Outlook of Immunotherapy for Colorectal Cancer
Neil H. Segal et al.
CURRENT COLORECTAL CANCER REPORTS (2015)
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
Ana-Luisa Silva et al.
BMC CANCER (2014)
A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer
Jorge Barbazan et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
Fei Duan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases
S. Park et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
The Molecular Chaperone Apolipoprotein J/Clusterin as a Sensor of Oxidative Stress: Implications in Therapeutic Approaches - A Mini-Review
Ioannis P. Trougakos
GERONTOLOGY (2013)
The serrated pathway to colorectal carcinoma: current concepts and challenges
Mark Bettington et al.
HISTOPATHOLOGY (2013)
GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer
N. Li et al.
ONCOGENE (2013)
Correction: Non-Secreted Clusterin Isoforms Are Translated in Rare Amounts from Distinct Human mRNA Variants and Do Not Affect Bax-Mediated Apoptosis or the NF-κB Signaling Pathway
Hans Prochnow et al.
PLoS One (2013)
Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer
Patricia A. Tang et al.
CLINICAL CANCER RESEARCH (2012)
Small heat shock proteins in cancer therapy and prognosis
Amina Zoubeidi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
The Role of Clusterin in Alzheimer's Disease: Pathways, Pathogenesis, and Therapy
Jin-Tai Yu et al.
MOLECULAR NEUROBIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
J. Cassidy et al.
BRITISH JOURNAL OF CANCER (2011)
Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer
Nancy E. Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer
Amina Zoubeidi et al.
CLINICAL CANCER RESEARCH (2010)
Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas
Maximino Redondo et al.
HISTOPATHOLOGY (2010)
Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays
J. Bi et al.
NEOPLASMA (2010)
Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma
Li-Ru He et al.
CANCER SCIENCE (2009)
Regulation of Clusterin Expression in Human Cancer via DNA Methylation
Alfonso Serrano et al.
TUMOR BIOLOGY (2009)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol
Philippe Nizard et al.
TRAFFIC (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
J. R. Jass
HISTOPATHOLOGY (2007)
Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases
Ioannis P. Trougakos et al.
FREE RADICAL RESEARCH (2006)
PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion
PA Saunders et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor
Paola Mazzarelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Clusterin regulates drug-resistance in melanoma cells
C Hoeller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma
D Xie et al.
CANCER (2005)
Ca2+ depletion induces nuclear clusterin, a novel effector of apoptosis in immortalized human prostate cells
AE Caccamo et al.
CELL DEATH AND DIFFERENTIATION (2005)
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Modulation of different clusterin isoforms in human colon tumorigenesis
S Pucci et al.
ONCOGENE (2004)
Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells
M Scaltriti et al.
CANCER RESEARCH (2004)
Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin
AE Caccamo et al.
BIOCHEMICAL JOURNAL (2004)
Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis
M Scaltriti et al.
BRITISH JOURNAL OF CANCER (2004)
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer
M Scaltriti et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Photofrin as a radiosensitizer in an in vitro cell survival assay
U Kulka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Synthesis and functional analyses of nuclear clusterin, a cell death protein
KS Leskov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Clusterin/Apolipoprotein J in human aging and cancer
IP Trougakos et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Expression of clusterin in human pancreatic cancer
MJ Xie et al.
PANCREAS (2002)
The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma
Y Komuro et al.
CANCER (2002)
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression
S Bettuzzi et al.
ONCOGENE (2002)
Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy
LV July et al.
PROSTATE (2002)
Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence
H Miyake et al.
UROLOGY (2002)
Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies
S Pucci et al.
ONCOGENE (2001)
Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state
S Poon et al.
BIOCHEMISTRY (2000)
Overexpression of clusterin in human breast carcinoma
M Redondo et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
